Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About Ember Therapeutics, Inc. (OTC: EMBT)
Ember Therapeutics is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein BMP and related family of BMPs, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
- Phone: 6466124000
- Henrique Elache Cavalcanti / IR
- Joseph Hernandez / Executive Chairman
Current Share Structure
- Market Cap: $12,000,000 - 03/19/2018
- Authorized: 50,000,000 - 02/03/2016
- Issue and Outstanding: 40,000,000 - 02/03/2016
- Float: 578,500 - 02/03/2016
Daily Technical Chart for (OTC: EMBT)
Stay tuned for daily updates and more on (OTC: EMBT)
More to come on (OTC: EMBT)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EMBT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EMBT and does not buy, sell, or trade any shares of EMBT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/